XML 19 R11.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Fair Value Measurements and Fair Value of Instruments | 3 Months Ended
--- | ---
Mar. 31, 2024
Fair Value Disclosures [Abstract] |
Fair Value Measurements and Fair Value of Instruments | NOTE 3. FAIR VALUE MEASUREMENTS AND FAIR VALUE OF INSTRUMENTS The following tables display the carrying values and fair values of financial instruments.
|  |  |  | As of |
|  |  |  | March 31, 2024 |  |  | December 31, 2023 |
Assets on the Consolidated Balance Sheets |  |  |  | Carrying Value |  |  | Unrealized Losses |  |  | Fair Value |  |  | Carrying Value |  |  | Unrealized Losses |  |  | Fair Value |
Cash and cash equivalents |  | Level 1 |  | $ | 204,701 |  |  | $ | - |  |  | $ | 204,701 |  |  | $ | 215,214 |  |  | $ | - |  |  | $ | 215,214 |
Restricted cash |  | Level 1 |  |  | 247 |  |  |  | - |  |  |  | 247 |  |  |  | 495 |  |  |  | - |  |  |  | 495 |
Total |  |  |  | $ | 204,948 |  |  | $ | - |  |  | $ | 204,948 |  |  | $ | 215,709 |  |  | $ | - |  |  | $ | 215,709 |
The Company reports the current portion of restricted cash as a separate item in the Consolidated Balance Sheets and the non-current portion is a component of other long-term assets in the Consolidated Balance Sheets.
|  |  |  | As of |
|  |  |  | March 31, 2024 |  |  | December 31, 2023 |
Liabilities on the Consolidated Balance Sheets |  |  |  | Carrying Value |  |  | Fair Value |  |  | Carrying Value |  |  | Fair Value |
Acquisition earnout payment |  | Level 3 |  | $ | 2,800 |  |  | $ | 2,800 |  |  | $ | 4,250 |  |  | $ | 4,250 |
Total liabilities |  |  |  | $ | 2,800 |  |  | $ | 2,800 |  |  | $ | 4,250 |  |  | $ | 4,250 |
In December 2021, the Company purchased all of the outstanding equity interests of iQuue, LLC ("iQuue"). The Company reports the current portion of the acquisition earnout payment as a component of other current liabilities in the Consolidated Balance Sheets and the non-current portion is a component of other long-term liabilities on the Consolidated Balance Sheets. Earnout payments related to acquisitions are measured at fair value each reporting period using Level 3 unobservable inputs. The changes in the fair value of the Company's Level 3 liabilities for the three months ended March 31, 2024 and year ended December 31, 2023 are as follows.
|  |  |  | As of |
|  |  |  | March 31, 2024 |  |  | December 31, 2023 |
Balance at beginning of period |  |  |  | $ | 4,250 |  |  | $ | 5,540 |
Payment of earnout in connection with the iQuue acquisition |  |  |  |  | (1,530 | ) |  |  | (1,702 | )
Change in fair value of earnout |  |  |  |  | 80 |  |  |  | 412 |
Balance at end of period |  |  |  | $ | 2,800 |  |  | $ | 4,250 |
The fair value of the earnout payment is measured on a recurring basis at each reporting date. The following inputs and assumptions were used in the Monte Carlo simulation model to estimate the fair value of the earnout payment as of March 31, 2024 and December 31, 2023. During the three months ended March 31, 2024, the Company determined there was an $80 increase in the fair value of the earnout, primarily due to a decreased payment term as the Company is three months closer to the payout date. During the three months ended March 31, 2023, there was a $141 increase in the fair value of the earnout, primarily due to a change in the discount rate. The Company recorded these adjustments in general and administrative expense on the Consolidated Statement of Operations and Comprehensive Loss. The following table sets forth the weighted-average assumptions used to estimate the fair value of the earnout payment as of March 31, 2024 and December 31, 2023.
|  |  |  | As of |
|  |  |  | March 31, 2024 |  |  | December 31, 2023 |
Discount Rate |  |  |  |  | 10.90 | % |  |  | 10.50 | %
Volatility |  |  |  |  | 40.00 | % |  |  | 42.00 | %

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration